Clinical Trial Update: Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of an investigational Novo Nordisk drug to treat liver diseases is currently recruiting, including healthy volunteers and particip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis

Drugs mentioned

• Investigational drug (unnamed)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Hepatic Steatosis | Phase 1 | Status: RECRUITING